Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies

Acta Tropica

Volumn 64, Issue 3-4, 1997, Pages 145-154

  Konstantinov, S M ^a   Kaminsky, R ^b   Brun, R ^b   Berger, M R ^a   Zillmann, U ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

alkylphosphocholines; chemotherapy; growth inhibition; hexadecylphosphocholine; Trypanosoma brucei subspecies; Trypanosomatidae

Indexed keywords

HEXADECYLPHOSPHO(N,N,N TRIMETHYL)HEXANOLAMINE; MILTEFOSINE; OCTADECYL [2 (N METHYLPIPERIDINO)ETHYL]PHOSPHATE; OCTADECYLPHOSPHOCHOLINE; PHENYLBUTAZONE; PHOSPHORYLCHOLINE; TETRADECYLPHOSPHOCHOLINE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; TREATMENT OUTCOME; TRYPANOSOMA BRUCEI;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PHENYLBUTAZONE; PHOSPHORYLCHOLINE; PIPERIDINES; PLATELET ACTIVATING FACTOR; SPECIFIC PATHOGEN-FREE ORGANISMS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

TRYPANOSOMA; TRYPANOSOMA BRUCEI; TRYPANOSOMATIDAE;

EID: 0030893937     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(96)00628-6     Document Type: Article

References (21)

1. Bacchi, C.J., Brun, R., Croft, S.L., Alicea, K. and Bühler, Y. (1996) In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob. Agents and Chemother. 40/6, 1448-1453.
2. Bacchi, C.J., Nathan, H.C., Hutner, S.H., McCann, P.P. and Sjoerdsma, A. (1980) Polyamine metabolism: a potential therapeutic target in trypanosomes. Science 210, 332-334.
3. Baltz, T., Baltz, D., Giroud, C. and Crockett, J. (1985) Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J. 4, 1273-1277.
4. Berger, M.R., Betsch, B., Gebelein, M., Amtmannn, E., Heyl, P. and Scherf, H.R. (1993) Hexadecylphosphocholine differs from conventional cytostatic agents. J. Cancer Res. Clin. Oncol. 119, 541-548.
5. Berger, M.R., Yanapirut, P., Reinhardt, M., Klenner, T., Scherf, H.R., Schmeiser, H.H. and Eibl, H. (1992) Antitumor activity of alkylphosphocholines and analogues in methylnitrosourea-induced rat mammary carinoma. In: H. Eibl, P. Hilgard and C. Unger (Eds.), Alkylphosphocholines: New drugs in cancer therapy, Prog. Exp. Tumor Res., Vol. 34, Karger, Basel, pp, 98-115.
6. Brun, R., Bühler, Y., Sandmeier, U., Kaminsky, R., Bacchi, C.J., Rattendi, D., Lane, S., Croft, S.L., Snowdon, D., Yardley, V., Caravatti, G., Frei, J., Stanek, J. and Mett, H. (1996) In vitro trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors. Antimicrob. Agents Chemother. 40/6, 1442-1447.
7. Brun, R. and Lun, Z.R. (1994) Drug sensitivity of Chinese Trypanosoma evansi and Trypanosoma equiperdum isolates. Veterinary Parasitology 52, 37-46.
8. Haberkorn, A. (1979) The effect of Nifurtimox on experimental infections with trypanosomatidae other than Trypanosoma cruzi. Zentralbl. Bakteriol. Parasitenkd. Infektionskrankh. Hyg., 1e, Abt. Originale 244, 331-338.
9. Kaminsky, R. and Brun, R. (1993) In vitro assays to determine drug sensitivities of African trypanosomes: a review. Acta Tropica 54, 279-289.
10. Kaminsky, R., Schmid, C., Grether, Y., Holý, A., De Clercq, E., Naesens, L. and Brun, R. (1996) (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine [(S)-HPMPA]: a purine analogue with trypanocidal activity in vitro and in vivo. Trop. Med. Internat. Health 1/2, 255-263.
11. Kuhlencord, A., Maniera, T., Eibl, H. and Unger C. (1992) Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrob. Agents Chemother. 36, 1630-1634.
12. Kötting, J., Berger, M.R., Unger, C. and Eibl, H. (1992) Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother. Pharmacol. 30, 105-112.
13. Loiseau, P.M., Trabelsi, M., Gayral, P. and Wolf, J.G. (1995) The incorporation of N, N′-bis (2,3-dihydroxybenzoyl)-1,6 diazahexane or octane as the ligands of spiroarsoranes: their effect on trypanocidal activity. Acta Tropica 59, 237-241.
14. Pfeifer, S. (1995) Pharmacokinetic drug interactions. Pharmazie 50, 163-332.
15. Van Nieuwenhove, S. (1992) Advances in sleeping sickness therapy. Ann. Soc. Belg. Méd. Trop. 72 (1), 39-51.
16. Veeken, H.J.G.M., Ebeling, M.C.A. and Dolmans, W.M.V. (1989) Trypanosomiasis in a rural hospital in Tanzania: a retrospective study of its management and the results of treatment. Trop. Geogr. Med. 41, 113-117.
17. Vehmeyer, K., Eibl, H. and Unger, C. (1992) Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoetic progenitor cells. Exp. Hematol. 20, 1-5.
18. Walker, P.J. (1972) Capillary concentration technique applicable to infections of T. congolense in cattle. Trans. Roy. Soc. Trop. Med. Hyg. 66, 348.
19. Wéry, M. (1994) Drugs used in the treatment of sleeping sickness (human African trypanosomiasis: HAT). Int. J. Antimicrob. Agents. 4, 227-238.
20. WHO, (1994) Press Release/73, 7th Oct. 1994.
21. Woo, P.T.K. (1969) The haematocrit centrifuge for the detection of trypanosomes in blood. Canad. J. Zool. 47, 921-923.